JP2020531462A5 - - Google Patents

Download PDF

Info

Publication number
JP2020531462A5
JP2020531462A5 JP2020508983A JP2020508983A JP2020531462A5 JP 2020531462 A5 JP2020531462 A5 JP 2020531462A5 JP 2020508983 A JP2020508983 A JP 2020508983A JP 2020508983 A JP2020508983 A JP 2020508983A JP 2020531462 A5 JP2020531462 A5 JP 2020531462A5
Authority
JP
Japan
Prior art keywords
oil
composition according
composition
pores
surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020508983A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020531462A (ja
JP7311160B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/046918 external-priority patent/WO2019036625A1/en
Publication of JP2020531462A publication Critical patent/JP2020531462A/ja
Publication of JP2020531462A5 publication Critical patent/JP2020531462A5/ja
Application granted granted Critical
Publication of JP7311160B2 publication Critical patent/JP7311160B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020508983A 2017-08-18 2018-08-17 ドライアイ症候群を診断及び処置する方法及びヒトの眼を処置するための組成物 Active JP7311160B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762547553P 2017-08-18 2017-08-18
US62/547,553 2017-08-18
PCT/US2018/046918 WO2019036625A1 (en) 2017-08-18 2018-08-17 METHODS FOR DIAGNOSING AND TREATING DRY-LIKE SYNDROME AND COMPOSITIONS FOR TREATING A HUMAN EYE

Publications (3)

Publication Number Publication Date
JP2020531462A JP2020531462A (ja) 2020-11-05
JP2020531462A5 true JP2020531462A5 (OSRAM) 2021-09-24
JP7311160B2 JP7311160B2 (ja) 2023-07-19

Family

ID=65363005

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020508983A Active JP7311160B2 (ja) 2017-08-18 2018-08-17 ドライアイ症候群を診断及び処置する方法及びヒトの眼を処置するための組成物

Country Status (7)

Country Link
US (2) US11622982B2 (OSRAM)
EP (1) EP3668474A4 (OSRAM)
JP (1) JP7311160B2 (OSRAM)
CN (2) CN114376961A (OSRAM)
BR (1) BR112020003276A2 (OSRAM)
CA (1) CA3072494A1 (OSRAM)
WO (1) WO2019036625A1 (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018035469A1 (en) 2016-08-19 2018-02-22 Akrivista, LLC Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
EP3668474A4 (en) 2017-08-18 2021-05-26 Akrivista, LLC METHODS OF DIAGNOSIS AND TREATMENT OF DRY EYE SYNDROME AND COMPOSITIONS FOR TREATMENT OF A HUMAN EYE
ES2994624T3 (en) * 2019-02-27 2025-01-27 Santen Pharmaceutical Co Ltd Ophthalmic composition containing diquafosol or salt thereof, vinyl-based polymer and cellulose-based polymer
PL3888634T3 (pl) * 2020-03-31 2023-09-11 Oy Finnsusp Ab Preparat oftalmiczny i jego zastosowanie
EP3919047A1 (en) 2020-06-03 2021-12-08 AZAD Pharma AG Microemulsion for the treatment of dry eye syndrome
ES2916152A1 (es) * 2020-12-28 2022-06-28 Univ Valladolid Compuestos para su uso en la prevencion y/o tratamiento de la inflamacion y el estres oxidativo del segmento anterior del ojo
CN112842936A (zh) * 2021-03-15 2021-05-28 傅博 一种眼部清洁液及其制备方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278447A (en) 1963-12-02 1966-10-11 Cloro Bac Products Inc Process for stabilizing chlorine dioxide solution
US4146499A (en) 1976-09-18 1979-03-27 Rosano Henri L Method for preparing microemulsions
US4585656A (en) 1984-08-20 1986-04-29 Rosenthal Harold R Treatment of herpes
CA2052950A1 (en) 1990-10-10 1992-04-11 David P. Evitts Aqueous ophthalmic microemulsions of tepoxalin
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
US5527488A (en) * 1992-08-07 1996-06-18 Amway Corporation High viscosity anhydrous makeup remover gel
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
US20030086986A1 (en) 1998-08-06 2003-05-08 Bruijn Chris De Ophthalmic, pharmaceutical and other healthcare preparations with naturally occurring plant compounds, extracts and derivatives
US7262224B2 (en) * 1999-11-30 2007-08-28 Hanna Isul Skin Therapy, Inc. Cosmetic rejuvenating and healing product, method of its manufacture and uses thereof
MXPA04003299A (es) 2001-10-11 2004-07-23 Alcon Inc Metodos para tratar la resequedad ocular mediante una combinacion de un esteroide antiinflamatorio y un secretagogo muc-1.
US6559182B1 (en) 2001-11-07 2003-05-06 Purcell Jojoba International, Llc Method for treatment of enveloped viruses using jojoba oil esters
US20060251685A1 (en) 2003-03-18 2006-11-09 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
WO2006004577A2 (en) 2004-03-12 2006-01-12 Melbj Holdings, Llc Lubricant for the ocular surface
US20050202097A1 (en) 2004-03-12 2005-09-15 Melbj Holdings, Llc, Florida Lubricant for the ocular surface
JP5272307B2 (ja) 2004-07-16 2013-08-28 大正製薬株式会社 水性点眼剤
WO2006073786A2 (en) 2004-12-30 2006-07-13 Bausch & Lomb Incorporated Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy
US9161905B2 (en) 2005-01-12 2015-10-20 Ocular Research Of Boston, Inc. Dry eye treatment
JP2006233398A (ja) 2005-02-23 2006-09-07 Daiwa Kagaku Kogyo Kk アボガド油及びアボガド油不けん化物を処理したことを特徴とする機能化繊維材料および機能化繊維材料の処理方法。
US8168655B2 (en) 2005-05-17 2012-05-01 Sarcode Bioscience Inc. Compositions and methods for treatment of eye disorders
AU2008219600A1 (en) 2007-02-28 2008-09-04 Aciex Therapeutics, Inc. Methods and compositions for normalizing meibomian gland secretions
FR2916636B1 (fr) 2007-05-29 2009-09-04 Octalia Technologies Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation ophtalmique ou dermocosmetique
US8669241B2 (en) 2008-12-02 2014-03-11 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition
MX2011013060A (es) 2009-06-05 2012-02-28 Aciex Therapeutics Inc Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas.
US8496976B2 (en) 2009-06-05 2013-07-30 Allergan, Inc. Artificial tears and therapeutic uses
JP5673531B2 (ja) 2009-06-30 2015-02-18 ライオン株式会社 眼科用組成物
US8909327B1 (en) * 2010-06-23 2014-12-09 Allergan, Inc. Instrument and method for diagnosing dry eye in a patient
WO2012092320A2 (en) 2010-12-29 2012-07-05 Nichamin Louis D Eye treatment
US20140302146A1 (en) 2011-07-08 2014-10-09 Rohto Pharmaceutical Co.,Ltd. Ophthalmic Aqueous Composition
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
EP2787969B1 (en) 2011-12-07 2021-09-29 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
ITFI20120044A1 (it) 2012-03-01 2013-09-02 Biodue Spa Formulazione ad uso oftalmico comprendente olio di jojoba.
JP5988855B2 (ja) 2012-06-27 2016-09-07 ロート製薬株式会社 水性眼科組成物
JP6275820B2 (ja) 2014-03-10 2018-02-07 サラヤ株式会社 ソホロリピッドと生理活性物質と油脂とを含有する組成物およびその製造方法
EP3223794A1 (en) 2014-11-25 2017-10-04 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
RS58292B1 (sr) 2016-07-07 2019-03-29 Salvat Lab Sa Oftalmološka kompozicija sa ricinusovim uljem i srednjim lancem triglicerida
WO2018035469A1 (en) 2016-08-19 2018-02-22 Akrivista, LLC Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
CN106389218A (zh) 2016-10-28 2017-02-15 林振慧 一种眼部凝露
EP3668474A4 (en) 2017-08-18 2021-05-26 Akrivista, LLC METHODS OF DIAGNOSIS AND TREATMENT OF DRY EYE SYNDROME AND COMPOSITIONS FOR TREATMENT OF A HUMAN EYE

Similar Documents

Publication Publication Date Title
RU2015154403A (ru) Офтальмическая наноэмульсионная композиция, содержащая циклоспорин и способ ее получения
JP6757435B2 (ja) 眼科用水性組成物
RU2423128C2 (ru) Фармацевтическая композиция для наружного применения
MX2013006816A (es) Formulaciones farmaceuticas de azol para la administracion parenteral y metodos para preparar y usar las mismas como tratamiento de las enfermedades sensibles a los compuestos de azol.
NZ727975A (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
ZA202100855B (en) Personal care compositions
MX2024000828A (es) Formulaciones de parasiticida de isoxazolina y metodos para el tratamiento de la blefaritis.
JP5966228B2 (ja) アリピプラゾール組成物
CN104302281A (zh) 包含特比萘芬与尿素的局部药物组合物
CN101313904A (zh) 一种用于治疗外阴道炎的芬替康唑栓剂
CN101342174B (zh) 一种酞丁安/达克罗宁的复方局部用制剂
CN1286529C (zh) 具有皮肤靶向性的药物组合物及其制备方法和用途
RU2007149249A (ru) Глазные капли, содержащие рофлумиласт
DE202015100655U1 (de) Pharmazeutische Zusammensetzung zur topischen Anwendung im Gehörgang
CN105997529A (zh) 一种膜剂型健康止痒驱蚊虫水
CN105411998B (zh) 含有五味子乙素的治疗烧烫伤的外用组合物
TW201622700A (zh) 水性醫藥組成物
CN117500488A (zh) 包含阿米替林和碱性水相的局部药物组合物
JP4778262B2 (ja) 角膜疾患治療剤
EA202290122A1 (ru) Фармацевтические композиции в форме геля, содержащие ксилоглюкан и спирты, для регулируемого высвобождения активных ингредиентов
WO2020237248A8 (en) Compositions and methods for treating presbyopia
JP2021527709A (ja) 漢方薬ゲル組成物及びその調製方法と用途
JP6370069B2 (ja) まつ毛の成長を伸展するための組成物
MX349868B (es) Composiciones de gel.
WO2025010400A3 (en) Compositions and methods for improved treatment of skin wounds